Clinical trials are critical to advancing lifesaving medications and treatments. But the U.S. is falling woefully short in making sure that these trials represent the broader population, as some researchers don’t even record the racial and ethnic makeup of the people in their trials.
Improving diversity in clinical trials is one of the most important steps needed to achieve health equity. The reasons for this underrepresentation are myriad and complex. Obstacles range from individuals not having physical access to clinical trial sites, to general distrust of the medical institutions running the research, to a lack of proper community outreach. How can researchers overcome these challenges and champion the importance of increasing diversity in clinical trials to the medical community at large?